Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 447 entries
Sorted by: Best Match Show Resources per page
The 5-hydroxytryptamine transporter is functional in human coronary artery smooth muscle cells proliferation and is regulated by Interleukin-1 beta.

International journal of clinical and experimental medicine

Wang QJ, Wang D, Tang CC.
PMID: 26221231
Int J Clin Exp Med. 2015 May 15;8(5):6947-56. eCollection 2015.

Abnormal human coronary artery smooth muscle cells (hCASMCs) proliferation and migration are key factors in coronary artery restenosis after percutaneous coronary intervention. Platelets release 5-hydroxytryptamine (5-HT), which is a strong mitogen for pulmonary artery smooth muscle cells proliferation and...

Cite
Wang QJ, Wang D, Tang CC. The 5-hydroxytryptamine transporter is functional in human coronary artery smooth muscle cells proliferation and is regulated by Interleukin-1 beta. Int J Clin Exp Med. 2015;8(5):6947-56
Wang, Q. J., Wang, D., & Tang, C. C. (2015). The 5-hydroxytryptamine transporter is functional in human coronary artery smooth muscle cells proliferation and is regulated by Interleukin-1 beta. International journal of clinical and experimental medicine, 8(5), 6947-56.
Wang, Qing-Jie, et al. "The 5-hydroxytryptamine transporter is functional in human coronary artery smooth muscle cells proliferation and is regulated by Interleukin-1 beta." International journal of clinical and experimental medicine vol. 8,5 (2015): 6947-56.
Wang QJ, Wang D, Tang CC. The 5-hydroxytryptamine transporter is functional in human coronary artery smooth muscle cells proliferation and is regulated by Interleukin-1 beta. Int J Clin Exp Med. 2015 May 15;8(5):6947-56. eCollection 2015. PMID: 26221231; PMCID: PMC4509176.
Copy Download .nbib Format: NLM
Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention.

Neuropsychiatric disease and treatment

Rahimi A, Ahmadpanah M, Shamsaei F, Cheraghi F, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S.
PMID: 27382293
Neuropsychiatr Dis Treat. 2016 Jun 22;12:1507-15. doi: 10.2147/NDT.S110978. eCollection 2016.

BACKGROUND: Sleep disturbances are a common co-occurring disturbance in patients with major depressive disorders (MDDs) and accordingly deserve particular attention. Using a randomized design, we investigated the effects of three different adjuvant interventions on sleep and depression among patients...

Cite
Rahimi A, Ahmadpanah M, Shamsaei F, et al. Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention. Neuropsychiatr Dis Treat. 2016;12:1507-15doi: 10.2147/NDT.S110978.
Rahimi, A., Ahmadpanah, M., Shamsaei, F., Cheraghi, F., Sadeghi Bahmani, D., Holsboer-Trachsler, E., & Brand, S. (2016). Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention. Neuropsychiatric disease and treatment, 121507-15. https://doi.org/10.2147/NDT.S110978
Rahimi, Alireza, et al. "Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention." Neuropsychiatric disease and treatment vol. 12 (2016): 1507-15. doi: https://doi.org/10.2147/NDT.S110978
Rahimi A, Ahmadpanah M, Shamsaei F, Cheraghi F, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S. Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention. Neuropsychiatr Dis Treat. 2016 Jun 22;12:1507-15. doi: 10.2147/NDT.S110978. eCollection 2016. PMID: 27382293; PMCID: PMC4922769.
Copy Download .nbib Format: NLM
Anxiety disorders: under-diagnosed and insufficiently treated.

International journal of psychiatry in clinical practice

Kasper S.
PMID: 24931537
Int J Psychiatry Clin Pract. 2006;10:3-9. doi: 10.1080/13651500600552297.

Anxiety disorders have a high prevalence, particularly specific phobia, social anxiety disorder (SAD), post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD). The lifetime prevalence for any anxiety disorder is almost 30%. Also, many anxiety disorders have a high...

Cite
Kasper S. Anxiety disorders: under-diagnosed and insufficiently treated. Int J Psychiatry Clin Pract. 2006;10:3-9doi: 10.1080/13651500600552297.
Kasper, S. (2006). Anxiety disorders: under-diagnosed and insufficiently treated. International journal of psychiatry in clinical practice, 103-9. https://doi.org/10.1080/13651500600552297
Kasper, Siegfried. "Anxiety disorders: under-diagnosed and insufficiently treated." International journal of psychiatry in clinical practice vol. 10 (2006): 3-9. doi: https://doi.org/10.1080/13651500600552297
Kasper S. Anxiety disorders: under-diagnosed and insufficiently treated. Int J Psychiatry Clin Pract. 2006;10:3-9. doi: 10.1080/13651500600552297. PMID: 24931537.
Copy Download .nbib Format: NLM
The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds.

Behavioural pharmacology

Baker LE, Riddle EE, Saunders RB, Appel JB.
PMID: 11224173
Behav Pharmacol. 1993 Feb;4(1):69-79.

The involvement of monoamine neurotransmitter uptake in the discriminative stimulus effects of cocaine was examined in rats (n = 48) trained to discriminate 10mg/kg of this substance from saline in a two-level, water-reinforced (FR 20), drug discrimination situation. Compounds...

Cite
Baker LE, Riddle EE, Saunders RB, et al. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol. 1993;4(1):69-79
Baker, L. E., Riddle, E. E., Saunders, R. B., & Appel, J. B. (1993). The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behavioural pharmacology, 4(1), 69-79.
Baker, L.E., et al. "The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds." Behavioural pharmacology vol. 4,1 (1993): 69-79.
Baker LE, Riddle EE, Saunders RB, Appel JB. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol. 1993 Feb;4(1):69-79. PMID: 11224173.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayes M, Rabasseda X, Prous JR.
PMID: 11980386
Methods Find Exp Clin Pharmacol. 2002 Jan-Feb;24(1):37-55.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses, which has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the world's first drug discovery and development...

Cite
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002;24(1):37-55
Bayes, M., Rabasseda, X., & Prous, J. R. (2002). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 24(1), 37-55.
Bayes, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 24,1 (2002): 37-55.
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002 Jan-Feb;24(1):37-55. PMID: 11980386.
Copy Download .nbib Format: NLM
The involvement of dopamine (DA) and serotonin (5-HT) in stress-induced stereotypies in bank voles (Clethrionomys glareolus).

Applied animal behaviour science

Schoenecker B, Heller KE.
PMID: 11434965
Appl Anim Behav Sci. 2001 Aug 27;73(4):311-319. doi: 10.1016/s0168-1591(01)00143-5.

In order to clarify the dependency of stress-induced stereotypies on dopamine (DA) and serotonin (5-HT) functioning, undisturbed and acutely stressed stereotyping bank voles were treated during 3 weeks with the commonly used human atypical neurolepticum clozapine and the SSRI...

Cite
Schoenecker B, Heller KE. The involvement of dopamine (DA) and serotonin (5-HT) in stress-induced stereotypies in bank voles (Clethrionomys glareolus). Appl Anim Behav Sci. 2001;73(4):311-319doi: 10.1016/s0168-1591(01)00143-5.
Schoenecker, B., & Heller, K. E. (2001). The involvement of dopamine (DA) and serotonin (5-HT) in stress-induced stereotypies in bank voles (Clethrionomys glareolus). Applied animal behaviour science, 73(4), 311-319. https://doi.org/10.1016/s0168-1591(01)00143-5
Schoenecker, B, and Heller, K E.. "The involvement of dopamine (DA) and serotonin (5-HT) in stress-induced stereotypies in bank voles (Clethrionomys glareolus)." Applied animal behaviour science vol. 73,4 (2001): 311-319. doi: https://doi.org/10.1016/s0168-1591(01)00143-5
Schoenecker B, Heller KE. The involvement of dopamine (DA) and serotonin (5-HT) in stress-induced stereotypies in bank voles (Clethrionomys glareolus). Appl Anim Behav Sci. 2001 Aug 27;73(4):311-319. doi: 10.1016/s0168-1591(01)00143-5. PMID: 11434965.
Copy Download .nbib Format: NLM
Escitalopram: A New SSRI for the Treatment of Depression in Primary Care.

Primary care companion to the Journal of clinical psychiatry

Culpepper L.
PMID: 15014711
Prim Care Companion J Clin Psychiatry. 2002 Dec;4(6):209-214. doi: 10.4088/pcc.v04n0601.

Escitalopram is the S-enantiomer of the racemic compound citalopram, a selective serotonin reuptake inhibitor (SSRI) widely used for the treatment of depression. This review describes the current body of pharmacologic and clinical evidence supporting the use of escitalopram for...

Cite
Culpepper L. Escitalopram: A New SSRI for the Treatment of Depression in Primary Care. Prim Care Companion J Clin Psychiatry. 2002;4(6):209-214doi: 10.4088/pcc.v04n0601.
Culpepper, L. (2002). Escitalopram: A New SSRI for the Treatment of Depression in Primary Care. Primary care companion to the Journal of clinical psychiatry, 4(6), 209-214. https://doi.org/10.4088/pcc.v04n0601
Culpepper, Larry. "Escitalopram: A New SSRI for the Treatment of Depression in Primary Care." Primary care companion to the Journal of clinical psychiatry vol. 4,6 (2002): 209-214. doi: https://doi.org/10.4088/pcc.v04n0601
Culpepper L. Escitalopram: A New SSRI for the Treatment of Depression in Primary Care. Prim Care Companion J Clin Psychiatry. 2002 Dec;4(6):209-214. doi: 10.4088/pcc.v04n0601. PMID: 15014711; PMCID: PMC315490.
Copy Download .nbib Format: NLM
Citalopram in the treatment of depression in the elderly.

Archives of gerontology and geriatrics. Supplement

Raffaele R, Vecchio I, Giammona G, Polizzi A, Ruggieri M, Malaguarnera M, Rampello L, Nicoletti F.
PMID: 14764407
Arch Gerontol Geriatr Suppl. 2002;8:303-8. doi: 10.1016/s0167-4943(02)00113-9.

No abstract available.

Cite
Raffaele R, Vecchio I, Giammona G, et al. Citalopram in the treatment of depression in the elderly. Arch Gerontol Geriatr Suppl. 2002;8:303-8doi: 10.1016/s0167-4943(02)00113-9.
Raffaele, R., Vecchio, I., Giammona, G., Polizzi, A., Ruggieri, M., Malaguarnera, M., Rampello, L., & Nicoletti, F. (2002). Citalopram in the treatment of depression in the elderly. Archives of gerontology and geriatrics. Supplement, 8303-8. https://doi.org/10.1016/s0167-4943(02)00113-9
Raffaele, R, et al. "Citalopram in the treatment of depression in the elderly." Archives of gerontology and geriatrics. Supplement vol. 8 (2002): 303-8. doi: https://doi.org/10.1016/s0167-4943(02)00113-9
Raffaele R, Vecchio I, Giammona G, Polizzi A, Ruggieri M, Malaguarnera M, Rampello L, Nicoletti F. Citalopram in the treatment of depression in the elderly. Arch Gerontol Geriatr Suppl. 2002;8:303-8. doi: 10.1016/s0167-4943(02)00113-9. PMID: 14764407.
Copy Download .nbib Format: NLM
Citalopram treatment for inappropriate sexual behavior in a cognitively impaired patient.

Primary care companion to the Journal of clinical psychiatry

Mania I, Evcimen H, Mathews M.
PMID: 16862238
Prim Care Companion J Clin Psychiatry. 2006;8(2):106. doi: 10.4088/pcc.v08n0208b.

No abstract available.

Cite
Mania I, Evcimen H, Mathews M. Citalopram treatment for inappropriate sexual behavior in a cognitively impaired patient. Prim Care Companion J Clin Psychiatry. 2006;8(2):106doi: 10.4088/pcc.v08n0208b.
Mania, I., Evcimen, H., & Mathews, M. (2006). Citalopram treatment for inappropriate sexual behavior in a cognitively impaired patient. Primary care companion to the Journal of clinical psychiatry, 8(2), 106. https://doi.org/10.4088/pcc.v08n0208b
Mania, Irakli, et al. "Citalopram treatment for inappropriate sexual behavior in a cognitively impaired patient." Primary care companion to the Journal of clinical psychiatry vol. 8,2 (2006): 106. doi: https://doi.org/10.4088/pcc.v08n0208b
Mania I, Evcimen H, Mathews M. Citalopram treatment for inappropriate sexual behavior in a cognitively impaired patient. Prim Care Companion J Clin Psychiatry. 2006;8(2):106. doi: 10.4088/pcc.v08n0208b. PMID: 16862238; PMCID: PMC1470648.
Copy Download .nbib Format: NLM
Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors.

Clinical practice and epidemiology in mental health : CP & EMH

Marazziti D, Dell'Osso B.
PMID: 16716210
Clin Pract Epidemiol Ment Health. 2006 May 22;2:9. doi: 10.1186/1745-0179-2-9.

Compulsive-Impulsive Sexual Behaviors (C-ISBs) include repetitive sexual acts and compulsive sexual thoughts which occur so frequently and with such intensity that they interfere with sexual intimacy and interpersonal and occupational functioning and whose categorization and effective treatments are still...

Cite
Marazziti D, Dell'Osso B. Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors. Clin Pract Epidemiol Ment Health. 2006;2:9doi: 10.1186/1745-0179-2-9.
Marazziti, D., & Dell'Osso, B. (2006). Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors. Clinical practice and epidemiology in mental health : CP & EMH, 29. https://doi.org/10.1186/1745-0179-2-9
Marazziti, Donatella, and Dell'Osso, Bernardo. "Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors." Clinical practice and epidemiology in mental health : CP & EMH vol. 2 (2006): 9. doi: https://doi.org/10.1186/1745-0179-2-9
Marazziti D, Dell'Osso B. Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors. Clin Pract Epidemiol Ment Health. 2006 May 22;2:9. doi: 10.1186/1745-0179-2-9. PMID: 16716210; PMCID: PMC1479813.
Copy Download .nbib Format: NLM
Biological therapies for obsessive-compulsive disorder.

Journal of psychiatric practice

Fallon BA, Mathew SJ.
PMID: 15990479
J Psychiatr Pract. 2000 May;6(3):113-28. doi: 10.1097/00131746-200005000-00002.

Two treatments have demonstrated efficacy in OCD, exposure and response (ritual) prevention (EX/RP) and pharmacotherapy with serotonin reuptake inhibitors (SRIs). In this article, which is the third in a three-part series, the authors present an overview of the role...

Cite
Fallon BA, Mathew SJ. Biological therapies for obsessive-compulsive disorder. J Psychiatr Pract. 2000;6(3):113-28doi: 10.1097/00131746-200005000-00002.
Fallon, B. A., & Mathew, S. J. (2000). Biological therapies for obsessive-compulsive disorder. Journal of psychiatric practice, 6(3), 113-28. https://doi.org/10.1097/00131746-200005000-00002
Fallon, B A, and Mathew, S J. "Biological therapies for obsessive-compulsive disorder." Journal of psychiatric practice vol. 6,3 (2000): 113-28. doi: https://doi.org/10.1097/00131746-200005000-00002
Fallon BA, Mathew SJ. Biological therapies for obsessive-compulsive disorder. J Psychiatr Pract. 2000 May;6(3):113-28. doi: 10.1097/00131746-200005000-00002. PMID: 15990479.
Copy Download .nbib Format: NLM
SSRI efficacy-finding the right dose.

Journal of psychiatric practice

Caley CF, Kando JC.
PMID: 15985852
J Psychiatr Pract. 2002 Jan;8(1):33-40. doi: 10.1097/00131746-200201000-00005.

The selective serotonin reuptake inhibitors (SSRIs) are a class of effective, well-tolerated antidepressants. They have a number of benefits compared with the tricyclic antidepressants (TCAs) including improved safety in overdose, reduced side-effect burden, and uncomplicated dosing regimens. To avoid...

Cite
Caley CF, Kando JC. SSRI efficacy-finding the right dose. J Psychiatr Pract. 2002;8(1):33-40doi: 10.1097/00131746-200201000-00005.
Caley, C. F., & Kando, J. C. (2002). SSRI efficacy-finding the right dose. Journal of psychiatric practice, 8(1), 33-40. https://doi.org/10.1097/00131746-200201000-00005
Caley, Charles F, and Kando, Judith C. "SSRI efficacy-finding the right dose." Journal of psychiatric practice vol. 8,1 (2002): 33-40. doi: https://doi.org/10.1097/00131746-200201000-00005
Caley CF, Kando JC. SSRI efficacy-finding the right dose. J Psychiatr Pract. 2002 Jan;8(1):33-40. doi: 10.1097/00131746-200201000-00005. PMID: 15985852.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 447 entries